Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 18, 2023 - Issue
Submit an article Journal homepage
1,065
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

Charlie Strange1 College of Medicine, The Medical University of South Carolina, Charleston, SC, USAORCID Iconhttps://orcid.org/0000-0002-8109-8067View further author information
ORCID Icon,
Joseph Tkacz2 Data Solutions, Inovalon, Bowie, MD, USAView further author information
,
Jill Schinkel2 Data Solutions, Inovalon, Bowie, MD, USAView further author information
,
Benjamin Lewing2 Data Solutions, Inovalon, Bowie, MD, USAView further author information
,
Barnabie Agatep2 Data Solutions, Inovalon, Bowie, MD, USAView further author information
,
Sean Swisher3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USAView further author information
,
Sushma Patel3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USAView further author information
,
Devechio Edwards3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USAView further author information
,
Daniel R Touchette4 College of Pharmacy - Pharmacy Systems Outcomes and Policy, University of Illinois Chicago, Chicago, IL, USAView further author information
,
Edward Portillo5 Pharmacy Practice & Translational Research Division, University of Wisconsin-Madison, Madison, WI, USAView further author information
,
Norbert Feigler3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USAView further author information
&
Michael Pollack3 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7351-3059View further author information
ORCID Icon show all
Pages 2245-2256 | Received 05 Aug 2023, Accepted 01 Oct 2023, Published online: 12 Oct 2023

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hana Müllerová, Jeffrey Shi Kai Chan, Heath Heatley, Victoria Carter, John Townend, Derek Skinner, Stefan Franzén, Jonathan Marshall & David Price. (2024) Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success. International Journal of Chronic Obstructive Pulmonary Disease 19, pages 1153-1166.
Read now

Articles from other publishers (3)

Sarah-Christin Mavi, Franziska Trudzinski, Konstantina Kontogianni & Frederik Trinkmann. (2024) Exazerbationen bei COPD: sicher beurteilen, adäquat behandeln. Pneumo News 16:3, pages 27-34.
Crossref
L. Biener, C. Pizarro & D. Skowasch. (2024) Chronisch-obstruktive Lungenerkrankung (COPD) – Eosinophilie und neue ArzneimitteltherapienChronic obstructive pulmonary disease (COPD): eosinophilia and novel drug therapies. Die Innere Medizin 65:7, pages 738-745.
Crossref
Dave Singh, MeiLan K. Han, Nathaniel M. Hawkins, John R. Hurst, Janwillem W. H. Kocks, Neil Skolnik, Daiana Stolz, Jad El Khoury & Chris P. Gale. (2024) Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review. Advances in Therapy 41:6, pages 2151-2167.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.